Table 4.
Percentage (mean ± standard deviation) of leukocyte subpopulations in peripheral blood of patients with tuberculous and neoplastic pleural effusions as compared to the control group
| Cells | Malignant | Tuberculous | Control | P |
|---|---|---|---|---|
| CD15 | 66.7 (8.2) | 62.4 (8.1) | 58.6 (13.9) | 0.176 |
| CD14 * | 7.4 (2.2) | 10.7 (3.0) | 7.7 (3.4) | 0.012 (2×1; 2×3) |
| CD14CD86 | 95.2 (10.6) | 99.3 (0.5) | 99.3 (0.5) | 0.143 |
| Lymphocytes | 20.5 (7.1) | 23.1 (6.8) | 27.6 (9.6) | 0.074 |
| CD3 * | 12.3 (5.1) | 13.9 (4.6) | 20.0 (9.4) | 0.014 (3×1) |
| CD20 | 2.9 (2.3) | 2.0 (1.1) | 3.1 (1.6) | 0.207 |
| CD56 | 3.3 (1.7) | 4.4 (2.5) | 3.5 (1.6) | 0.289 |
| CD20HLA | 99.1 (1.8) | 99.8 (0.3) | 99.8 (0.3) | 0.411 |
| CD20CD25 * | 7.0 (6.3) | 19.3 (18.6) | 7.0 (2.9) | 0.006 (2×1; 2×3) |
| CD20CD80 | 17.1 (30.4) | 9.8 (9.1) | 5.2 (4.6) | 0.391 |
| CD20CD86 * | 15.2 (19.6) | 22.4 (16.2) | 8.5 (11.9) | 0.004 (2×3) |
| CD3CD4 * | 47.8 (13.4) | 50.9 (14.0) | 64.4 (8.0) | 0.001 (3×1; 3×2) |
| CD3CD8 * | 44.8 (17.8) | 45.0 (13.7) | 32.3 (7.3) | 0.007 (2×3; 1×3) |
| CD3CD4/CD3CD8 * | 1.4 (0.9) | 1.3 (0.8) | 2.1 (0.7) | 0.008 (3×2; 3×1) |
| CD3TCRαβ | 91.9 (7.8) | 93.0 (5.4) | 89.8 (19.1) | 0.740 |
| CD3TCRγδ * | 6.3 (5.4) | 8.4 (5.3) | 4.7 (2.6) | 0.049 (2×3) |
| 002CD3CD45RA * | 53.2 (17.9) | 58.8 (11.8) | 39.7 (11.9) | 0.001 (2×3; 1×3) |
| CD3CD45RO | 56.0 (21.0) | 62.5 (10.3) | 59.2 (13.7) | 0.563 |
| CD3HLA * | 18.6 (12.9) | 22.0 (10.0) | 12.4 (6.0) | 0.023 (2×3) |
| CD3CD25 * * | 30.9 (15.6) | 27.2 (8.5) | 14.7 (4.9) | 0.001 (1×3; 2×3) |
| CD3CD28 * | 72.0 (11.6) | 70.6 (2.5) | 84.9 (7.7) | 0.001 (3×2; 3×1) |
| CD3CD80 * | 0.7 (0.6) | 1.0 (0.9) | 0.2 (0.2) | 0.001 (2×3; 1×3) |
| CD3CD95 | 79.3 (13.6) | 74.7 (16.5) | 76.7 (9.6) | 0.704 |
| CD3CD95L * | 16.2 (22.1) | 50.9 (34.7) | 13.2 (9.5) | 0.005 (2×1; 2×3) |
| CD3CD152 * | 5.2 (12.2) | 1.3 (1.4) | 0.5 (0.4) | 0.022 (2×3) |